Esanex, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2011-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.esanexpharma.com
Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2012-05-17
- Lead Sponsor
- Esanex Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT00595686
- Locations
- 🇺🇸
Pfizer Investigational Site, Nashville, Tennessee, United States
Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2012-05-28
- Lead Sponsor
- Esanex Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT00506805
- Locations
- 🇺🇸
Pfizer Investigational Site, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath